Amneal Pharmaceuticals Inc (AMRX): Operatsion marja

Ommaviy kompaniya Amneal Pharmaceuticals, Inc. (AMRX) logotipi

Amneal Pharmaceuticals (AMRX) uchun kengayish risklari zavod avtomatlashtirilganligiga bog'liqlik va mahsulotlar portfelining kengligi bilan bog'liq. Operatsion marjani kuzatish biznesning barqarorligini tasdiqlaydi, bunda 16.40 ushbu ko'rsatkichning joriy qiymatini ifodalaydi. Barqarorlik yuqori sifatli biosimilarlarning ishonchli yetkazib beruvchisi sifatidagi obro' bilan mustahkamlanadi, barqaror pul oqimi esa hamyonbop generiklarga bo'lgan yuqori talabning inertsiya tufayli kafolatlanadi, bu esa operatsion faoliyatning pasayishi belgilarini butunlay yo'q qiladi.

Amneal Pharmaceuticals, Inc. (AMRX): Operatsion rentabellik 04.07.2022dan 20.11.2026gacha

Amneal Pharmaceuticals (AMRX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
Kompaniyaning fundamental baholanishi:Amneal Pharmaceuticals, Inc., AMRX
Amneal Corp asosiy tovari

Amneal Pharmaceuticals (AMRX) moliyaviy barqarorligi distribyutorlarning generik ta'minotga bo'lgan mukammal ishonchiga asoslangan bo'lib, bu operatsion xatarlarni minimallashtiradi. Asosiy biznes marjasini tahlil qilish orqali investor soliqlar va foizlargacha bo'lgan umumiy daromadning operatsion foyda ulushini baholaydi, bu esa xarajatlarni boshqarish samaradorligini va ushbu grafikdagi narxlar dinamikasi orqali biznes daromadliligining fundamental rivojlanishini aniqlaydi.

Asosiy raqobatchilar

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Operatsion foyda bo'yicha marjinallik Perrigo Company PLC|Alvotech Biopharmaceuticals - Operatsion marja|Operatsion faoliyat rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Operatsion rentabellik|anipharmaceuticals.com - Operatsion foyda normasi|Sotuvning operatsion marjasi MNKD|AMPH: Operatsion foyda normasi|Operatsion rentabellik pacira.com (PCRX)|Operatsion marja ARS Pharma (SPRY)|Theravance Biopharma - Sotuvning operatsion marjasi|Operatsion foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Tectonic Therapeutic|TNXP: Operatsion marja|SXT China (SXTC) - Operatsion marja|Operatsion rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Invizyne (EXOZ)|ORMP - Sotuvning operatsion rentabelligi|Operatsion marja ENTX (Entera Bio)|Operatsion foyda bo'yicha marjinallik MindWalk Therapeutics|ABVC: Sotuvning operatsion marjasi|CPIX - Operatsion marja|QNTM (Quantum BioPharma) - Sotuvning operatsion marjasi|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.